Your SlideShare is downloading. ×
Global Dementia Legacy Event: Mr. George Vradenburg
Global Dementia Legacy Event: Mr. George Vradenburg
Global Dementia Legacy Event: Mr. George Vradenburg
Global Dementia Legacy Event: Mr. George Vradenburg
Global Dementia Legacy Event: Mr. George Vradenburg
Global Dementia Legacy Event: Mr. George Vradenburg
Global Dementia Legacy Event: Mr. George Vradenburg
Global Dementia Legacy Event: Mr. George Vradenburg
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Global Dementia Legacy Event: Mr. George Vradenburg

515

Published on

Session Four: Exploring the financial mechanisms that can be harnessed to increase investment in …

Session Four: Exploring the financial mechanisms that can be harnessed to increase investment in
dementia.

Mr. George Vradenburg, Convenor, The Global CEO Initiative on Alzheimer's and Chairman of USAgainstAlzheimer’s & World Dementia Council Member

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
515
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. George Vradenburg Convener, The Global CEO Initiative on Alzheimer’s Disease Member, World Dementia Council 1
  • 2. Mobilizing the Needed Resources Increasing our Productivity Increasing Investor Reward/Reducing their Risk Innovative Finance Mechanisms and Approaches 2
  • 3. Increasing our Productivity Global Alzheimer’s Platform 3Examples only, not comprehensive U.K. Dementia Platform Global Goals: Longitudinal Data, Biomarkers/Diagnostics, New Targets, Reduce Time/Cost to Market, Regulatory Alignment
  • 4. Increasing Investor Reward/Reducing Risk 4 Mechanism Example Reward: Extension of Exclusivity/IP Period Orphan Drug Policy Changes Risk: Shortening Development Times HIV/AIDS; Biomarkers + Conditional Approval; Trial- Ready Infrastructure Both: Reduce Uncertainty Accelerated and Globally Aligned Regulatory Pathways ►Here are mechanisms to change the risk/reward equation ►Each has been done elsewhere; we can do it
  • 5. Drug Discovery/ Diagnostics Care Delivery Venture Capital Drug Development Arc of Disease Management Finance Mechanisms - Today Government Grants 5 Non-Profit, Philanthropy Industry Private Equity Hedge Funds Today Innovative Finance Mechanisms and Approaches Basic Research Government
  • 6. Drug Discovery/ Diagnostics Care Delivery Basic Research Venture Capital Drug Development Arc of Disease Management Finance Mechanisms – In The Future Government Grants 6 Non-Profit, Philanthropy Industry Private Equity Hedge Funds Future Government Sovereign Wealth Crowd Funding Global Fund Social Impact Bonds Crowd Equity
  • 7. Government Drug Discovery/ Diagnostics Care Delivery Basic Research Venture Capital Drug Development Arc of Disease Management Finance Mechanisms – In The Future Government Grants 7 Non-Profit, Philanthropy Industry Private Equity Hedge Funds Future Crowd Funding Global Fund Crowd Equity Non-Profit, Philanthropy & Venture Capital Global Fund & Government & Industry Sovereign Wealth Social Impact Bonds Government & Private Equity
  • 8. THANK YOU 8 Maike Stenull, Johnson & Johnson Luc Truyen, Janssen (a Johnson & Johnson Company) Cynthia Duggan, New York Academy of Sciences The Member Companies of The Global CEO Initiative on Alzheimer’s

×